First-line antiretroviral therapy in Africa; how evidence-based are our recommendations?

R Colebunders, MR Kamya, J Laurence, A Kambugu, H Byakwaga, P Songa Mwebaze, A Muganzi Muganga, M Katwere, E Katabira, A Muganzi

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Original languageEnglish
    JournalAIDS Reviews
    Pages (from-to)148-154
    Publication statusPublished - 2005


    • B780-tropical-medicine
    • Viral diseases
    • HIV
    • AIDS
    • Antiretrovirals
    • Treatment guidelines
    • First-line drugs
    • Nevirapine
    • Efavirenz
    • Reverse transcriptase inhibitors
    • Non-nucleoside
    • Cost-effectiveness
    • Research needs
    • Clinical trials
    • Evidence-based medicine
    • Africa
    • Developing countries

    Cite this